2922-83-0
2922-83-0 結(jié)構(gòu)式
基本信息
L-犬尿氨酸
L-犬尿酸
L-2-AMINO-4-[2-AMINOPHENYL]-4-OXOBUTANOIC ACID
L-KYNURENINE
L-kynurenine free base
β-Anthraniloyl-L-alanine
β-Anthraniloyl-L-alanine, L-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid
L-Kynurenine Hydrate
(S)-2-Amino-4-oxo-4-(2-aminophenyl)butanoic acid
(S)-α,2-Diamino-γ-oxobenzenebutanoic acid
3-(2-Aminobenzoyl)alanine
3-(2-Aminobenzoyl)-L-alanine
物理化學(xué)性質(zhì)
安全數(shù)據(jù)
知名試劑公司產(chǎn)品信息
L-Kynurenine Hydrate,>98.0%(T)(2922-83-0)
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2026/03/03 | S5839 | L-犬尿氨酸 L-Kynurenine | 2922-83-0 | 5mg | 794.52元 |
| 2026/03/03 | S5839 | L-犬尿氨酸 L-Kynurenine | 2922-83-0 | 25mg | 2212.3元 |
| 2025/12/22 | HY-104026 | L-犬尿氨酸 L-Kynurenine | 2922-83-0 | 10 mg | 173元 |
常見問題列表
|
Human Endogenous Metabolite
|
Kynurenine and its further breakdown products carry out diverse biological functions, including dilating blood vessels during inflammation and regulating the immune response. Some cancers increase kynurenine production, which increases tumor growth. L-kynurenine (Kyn) is an aryl hydrocarbon receptor (AHR) agonist that activates AHR-directed, naive T cell polarization to the anti-inflammatory Treg phenotype. Kynurenine activates AHR signaling at physiological concentrations in H1L7.5c3 cells and acts as an AHR agonist after a 24-hr exposure by inducing the AHR-regulated luciferase gene in H1L7.5c3 mouse hepatocyte cells.
Kynurenine dilates arteries from rats as well as humans via Kv7 channels in the vascular smooth muscle. In rats, this tryptophan metabolite causes hypotension, which is partly counteracted by Kv7 channel inhibition. L-kynurenine administered 1 h before the hypoxia-ischemia shows a dose-dependent significant neuroprotective effect, with complete protection at a dose of 300 mg/kg. The induction of c-fos immunoreactivity in cerebral cortex is also blocked by this dose of L-kynurenine.